Isoenzyme specific PFK-2/FBPas-2 inhibition as an anti-cancer strategy
<p>High aerobic glycolytic capacity is correlated with poor prognosis and increased tumour aggressiveness. 6Phosphofructo-1-kinase catalyses the first irreversible step of glycolysis, and is activated by fructose-2,6-bisphosphate, a product of the kinase activity of four bifunctional isoenzyme...
Päätekijä: | Williams, J |
---|---|
Muut tekijät: | Harris, A |
Aineistotyyppi: | Opinnäyte |
Kieli: | English |
Julkaistu: |
2013
|
Aiheet: |
Samankaltaisia teoksia
-
Isoenzyme-specific PFK-2/FBPase-2 Inhibition as an Anti-cancer Strategy
Tekijä: Williams, J, et al.
Julkaistu: (2012) -
Design, synthesis and biological evaluation of glycosidase inhibitors in an anti-cancer setting
Tekijä: Glawar, AFG
Julkaistu: (2013) -
The synthesis and biological evaluation of novel N-acetylhexosaminidase inhibitors
Tekijä: Crabtree, E, et al.
Julkaistu: (2011) -
Functional and inhibition studies on 2-oxoglutarate-dependent oxygenases
Tekijä: Thalhammer, A
Julkaistu: (2012) -
New methods for nucleophilic fluorination
Tekijä: Cresswell, A
Julkaistu: (2011)